Emergency Diagnoses Tied to Higher Death Risk Across Conditions
Study finds patients diagnosed during emergencies face greater risk of death compared to nonemergency cases.
![]()
Study finds patients diagnosed during emergencies face greater risk of death compared to nonemergency cases.
![]()
Removing a gene from immune cells boosts their effectiveness against relapsed osteosarcoma in preclinical studies, paving the way for a clinical trial.
![]()
Personalized vaccine may reduce melanoma recurrence in high-risk patients, say Moderna and Merck.
![]()
Preliminary study suggests daily vitamin D supplementation may boost cognitive test performance by 13% in those with mild cognitive impairment and sleep disturbances.
![]()
Australian researchers discover a molecule linked to aggressive breast cancer, offering new treatment avenues.
![]()
New research shows younger adults with non-small cell lung cancer have more genetic changes that may respond to targeted therapies.
![]()
Access to clinical trials is hindered by geographic, financial, and logistical barriers, despite promising matches.
![]()
Stanford researchers develop a two-headed molecule that flips a lymphoma-driving protein into an agent of cell death in mice.
![]()
New research highlights how immunotherapy enables the body’s defenses to fight cancer more effectively.
![]()